Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Total Debt Growth (3y) (2023 - 2026)

Analysis

Starling Oncology (STLN) Total Debt Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn 10.19%
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn -4.16%
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn -1.07%
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn 7.41%
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn 5.64%
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn -2.61%
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn -
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn -3.63%
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn -
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn -1.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.55%
Mar 31, 2026 -1.45%
Dec 31, 2025 -1.35%
Sep 30, 2025 -1.23%
Dec 31, 2024 698.39%
Dec 31, 2023 93.80%